Calpain-10 haplotype combination and association with gestational diabetes mellitus

Obstetrics and Gynecology

Volumn 103, Issue 6, 2004, Pages 1235-1240

  Leipold, Heinz ^b   Knöfler, Martin ^b   Gruber, Christian ^b   Haslinger, Peter ^b   Bancher Todesca, Dagmar ^b   Worda, Christof ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CALPAIN 10; UNCLASSIFIED DRUG;

ADULT; ARTICLE; FEMALE; GENE AMPLIFICATION; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RESTRICTION MAPPING; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; BODY MASS; CASE CONTROL STUDY; GENETICS; GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; PREGNANCY;

ADULT; BODY MASS INDEX; CALPAIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HAPLOTYPES; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY;

EID: 3042534074     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000127790.15556.3d     Document Type: Article

References (20)

1. Sepe SJ, Connell FA, Geiss LS, Teutsch SM. Gestational diabetes. Incidence, maternal characteristics, and perinatal outcome. Diabetes 1985;34(suppl 2):13-6.
2. Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 1998;19:477-90.
3. Catalano PM, Drago NM, Amini SB. Longitudinal changes in pancreatic beta-cell function and metabolic clearance rate of insulin in pregnant women with normal and abnormal glucose tolerance. Diabetes Care 1998;21: 403-8.
4. Homko C, Sivan E, Chen X, Reece EA, Boden G. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab 2001;86:568-73.
5. Linne Y, Barkeling B, Rossner S. Natural course of gestational diabetes mellitus: long term follow up of women in the SPAWN study. BJOG 2002;109:1227-31.
6. Kjos SI, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA. Predicting future diabetes in Latino women with gestational diabetes: utility of the early postpartum glucose tolerance testing. Diabetes 1995;44:586-91.
7. Hanis CL, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P, Stirling B, et al. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 1996;13:161-6.
8. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000;26:163-75.
9. Cassell PG, Jackson AE, North BV, Evans JC, Syndercombe-Court D, Phillips C. Haplotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians. Diabetes 2002;51:1622-8.
10. Malecki MT, Moczulski DK, Klupa T, Wank K, Cyganek K, Frey J, et al. Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population. Eur J Endocrinol 2002;146:695-9.
11. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
12. Dyck R, Klomp H, Tan LK, Turnell RW, Boctor MA. A comparison of rates, risk factors, and outcomes of gestational diabetes between aboriginal and non-aboriginal women in the Saskatoon health district. Diabetes Care 2002;25:487-93.
13. MacNeill S, Dodds L, Hamilton DC, Armson BA, Vandenhof M. Rates and risk factors for recurrence of gestational diabetes. Diabetes Care 2001;24:659-62.
14. Henry OA, Beischer NA. Long-term implications of gestational diabetes for the mother. Baillieres Clin Obstet Gynaecol 1991;5:461-83.
15. Cheung NW, Byth K. Population health significance of gestational diabetes. Diabetes Care 2003;26:2005-9.
16. Fingerlin TE, Erdos MR, Watanabe RM, Wiles KR, Stringham HM, Mohlke KL, et al. Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort. Diabetes 2002;51:1644-8.
17. Daimon M, Oizumi T, Saitoh T, Kameda W, Yamaguchi H, Ohnuma H, et al. Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese. Diabetes Res Clin Pract 2002;6: 147-52.
18. Tsai HJ, Sun G, Weeks DE, Kaushal R, Wolujewicz M, McGarvey ST, et al. Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association. Am J Hum Genet 2001;69:1236-44.
19. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2004;27(suppl 1):S88-90.
20. Solomon CG, Willett WC, Carey VJ, Rich-Edwards J, Hunter DJ, Colditz GA, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997;278:1078-83.